Suppr超能文献

干细胞、衰老及癌症中Arf/p53活性增强。

Increased Arf/p53 activity in stem cells, aging and cancer.

作者信息

Carrasco-Garcia Estefania, Moreno Manuel, Moreno-Cugnon Leire, Matheu Ander

机构信息

Cellular Oncology Group, Biodonostia Institute, San Sebastian, Spain.

Ikerbasque, Basque Foundation, Bilbao, Spain.

出版信息

Aging Cell. 2017 Apr;16(2):219-225. doi: 10.1111/acel.12574. Epub 2017 Jan 19.

Abstract

Arf/p53 pathway protects the cells against DNA damage induced by acute stress. This characteristic is the responsible for its tumor suppressor activity. Moreover, it regulates the chronic type of stress associated with aging. This is the basis of its anti-aging activity. Indeed, increased gene dosage of Arf/p53 displays elongated longevity and delayed aging. At a cellular level, it has been recently shown that increased dosage of Arf/p53 delays age-associated stem cell exhaustion and the subsequent decline in tissue homeostasis and regeneration. However, p53 can also promote aging if constitutively activated. In this context, p53 reduces tissue regeneration, which correlates with premature exhaustion of stem cells. We discuss here the current evidence linking the Arf/p53 pathway to the processes of aging and cancer through stem cell regulation.

摘要

Arf/p53通路保护细胞免受急性应激诱导的DNA损伤。这一特性是其肿瘤抑制活性的原因。此外,它调节与衰老相关的慢性应激类型。这是其抗衰老活性的基础。确实,Arf/p53基因剂量增加显示出寿命延长和衰老延迟。在细胞水平上,最近已表明Arf/p53剂量增加可延缓与年龄相关的干细胞耗竭以及随后组织稳态和再生能力的下降。然而,如果p53持续激活,它也可促进衰老。在这种情况下,p53会减少组织再生,这与干细胞过早耗竭相关。我们在此讨论目前将Arf/p53通路通过干细胞调节与衰老和癌症过程联系起来的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8c/5334536/5dd08513a912/ACEL-16-219-g001.jpg

相似文献

1
Increased Arf/p53 activity in stem cells, aging and cancer.
Aging Cell. 2017 Apr;16(2):219-225. doi: 10.1111/acel.12574. Epub 2017 Jan 19.
2
The Arf/p53 pathway in cancer and aging.
Cancer Res. 2008 Aug 1;68(15):6031-4. doi: 10.1158/0008-5472.CAN-07-6851.
3
Anti-aging activity of the Ink4/Arf locus.
Aging Cell. 2009 Apr;8(2):152-61. doi: 10.1111/j.1474-9726.2009.00458.x.
4
Delayed ageing through damage protection by the Arf/p53 pathway.
Nature. 2007 Jul 19;448(7151):375-9. doi: 10.1038/nature05949.
5
Role of the E2F1-p19-p53 pathway in ischemic acute renal failure.
Nephron Physiol. 2005;101(2):p27-34. doi: 10.1159/000086642. Epub 2005 Jun 30.
6
Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3931-6. doi: 10.1073/pnas.0700093104. Epub 2007 Feb 27.
7
Tumor suppressor dosage regulates stem cell dynamics during aging.
Cell Cycle. 2007 Jan 1;6(1):52-5. doi: 10.4161/cc.6.1.3667. Epub 2007 Jan 4.
8
TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
J Cancer Res Clin Oncol. 2006 Jul;132(7):417-26. doi: 10.1007/s00432-006-0080-1. Epub 2006 Feb 3.
9
The tumor suppressor p53: cancer and aging.
Cell Cycle. 2008 Apr 1;7(7):842-7. doi: 10.4161/cc.7.7.5657. Epub 2008 Jan 23.
10
p53-Dependent and -independent functions of the Arf tumor suppressor.
Cold Spring Harb Symp Quant Biol. 2005;70:129-37. doi: 10.1101/sqb.2005.70.004.

引用本文的文献

1
Development of a microRNA-Based age estimation model using whole-blood microRNA expression profiling.
Noncoding RNA Res. 2025 Mar 3;12:81-91. doi: 10.1016/j.ncrna.2025.03.003. eCollection 2025 Jun.
3
Protein sumoylation in normal and cancer stem cells.
Front Mol Biosci. 2022 Dec 19;9:1095142. doi: 10.3389/fmolb.2022.1095142. eCollection 2022.
6
ZNF217: the cerberus who fails to guard the gateway to lethal malignancy.
Am J Cancer Res. 2021 Jul 15;11(7):3378-3405. eCollection 2021.
7
Aging-related genes are potential prognostic biomarkers for patients with gliomas.
Aging (Albany NY). 2021 May 4;13(9):13239-13263. doi: 10.18632/aging.203008.
8
SIRT1-induced deacetylation of Akt expedites platelet phagocytosis and delays HEMEC aging.
Mol Ther Nucleic Acids. 2021 Jan 26;23:1323-1333. doi: 10.1016/j.omtn.2021.01.023. eCollection 2021 Mar 5.
9
Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
Exp Ther Med. 2021 Apr;21(4):305. doi: 10.3892/etm.2021.9736. Epub 2021 Jan 29.
10
MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
J Bioenerg Biomembr. 2021 Apr;53(2):191-202. doi: 10.1007/s10863-021-09888-2. Epub 2021 Mar 8.

本文引用的文献

1
Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan.
Nature. 2016 Feb 11;530(7589):184-9. doi: 10.1038/nature16932. Epub 2016 Feb 3.
2
Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional decline.
Aging Cell. 2015 Aug;14(4):710-4. doi: 10.1111/acel.12343. Epub 2015 May 20.
4
Therapeutic targeting of replicative immortality.
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S104-S128. doi: 10.1016/j.semcancer.2015.03.007. Epub 2015 Apr 11.
5
p53 Enables metabolic fitness and self-renewal of nephron progenitor cells.
Development. 2015 Apr 1;142(7):1228-41. doi: 10.1242/dev.111617.
6
Reduced expression of MYC increases longevity and enhances healthspan.
Cell. 2015 Jan 29;160(3):477-88. doi: 10.1016/j.cell.2014.12.016. Epub 2015 Jan 22.
7
Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a.
Aging Cell. 2015 Feb;14(1):139-47. doi: 10.1111/acel.12279. Epub 2014 Dec 6.
8
Koschei the immortal and anti-aging drugs.
Cell Death Dis. 2014 Dec 4;5(12):e1552. doi: 10.1038/cddis.2014.520.
9
Disease-associated polymorphisms in 9p21 are not associated with extreme longevity.
Geriatr Gerontol Int. 2015 Jun;15(6):797-803. doi: 10.1111/ggi.12346. Epub 2014 Sep 26.
10
The rs1333049 polymorphism on locus 9p21.3 and extreme longevity in Spanish and Japanese cohorts.
Age (Dordr). 2014 Apr;36(2):933-43. doi: 10.1007/s11357-013-9593-0. Epub 2013 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验